Daniel Melman is a Partner in the Patent Litigation and Post Grant Proceedings Groups at Pearl Cohen's New York office. He is an experienced intellectual property litigation and trial attorney, with a focus on patent, trade secret and other complex matters across various technologies, including telecommunications, computer hardware and software, medical devices, electro-mechanical devices, biotechnology, financial services, e-commerce, and the internet. He concentrates his practice on formulating and directing the protection and commercialization of intellectual property assets.
Daniel has taken lead roles in all aspects and phases of litigation, trials, and appeals in federal courts throughout the United States, in the United States Patent Office, and in the International Trade Commission as well as coordinating multinational parallel litigation proceedings. He is also registered to practice before the United States Patent and Trademark Office. Prior to attending law school, Daniel worked as an engineer at a Fortune 1000 leading supplier of filtration, separation, and purification technologies.
• Tjat Systems v. Expedia, Inc., Case No. 1:16-cv-00581 (D. Del. 2016) (pending) (E-commerce and internet server technology). Representing plaintiff patent owner in an action for patent infringement.
• RegenLab USA LLC v. Estar Technologies Ltd., Case No. 1:16-cv-8771 (S.D.N.Y. 2016) (pending) (platelet rich plasma technology). Patent infringement.
• Karmon v. Miambe Ltd., Case No. 1:16-cv-01643-DLC (S.D.N.Y. 2015) (dental implant devices) Patent infringement on behalf of patent owner. Case settled favorably.
• On Track Innovations Ltd. v. T-Mobile USA, Inc., Case No. 1:12-cv-2224 (S.D.N.Y. 2012) (near field communication and mobile devices) Patent infringement on behalf of patent owner. Case settled favorably following successful Markman decision and summary judgment ruling of infringement.
• Realtime Data LLC v. Morgan Stanley, Case No. 1:11cv6696 (S.D.N.Y. 2012) (financial data compression) Patent infringement. Case settled favorably.
• LG Electronics v. Iridian, Case No. 2:04cv391 (D.N.J. 2007) (biometrics) Patent and copyright infringement, trade secret misappropriation, breach of contract, and antitrust violations. Case settled on favorable terms.
• Donnelly v. Reitter & Schefenacker, Case No. 1:00cv751 (W.D. Mich. 2002) (electro-mechanical automotive devices) Patent infringement on behalf of patent owner. Case settled favorably following successful Markman decision.
• Litton v. Pirelli, Case No. 00-cv-10584 (C.D. Cal. 2008) (fiber optic amplifiers) Patent infringement. Case settled favorably prior to trial.
• Yeda v. ImClone, Case No. 1:03cv8484, 443 F.Supp.2d 570 (S.D.N.Y. 2006) (anti-cancer therapy) Represented the Weizmann Institute of Science in an action to correct the inventorship of a patent covering the use of ImClone’s blockbuster monoclonal antibody Erbitux® (cetuximab). Case settled favorably following a plenary trial and decision on the merits in favor of Weizmann.
• Samsung v. Ericsson, Inv. No. 337-TA-866 (ITC 2013) (LTE systems) Patent infringement. Case settled favorably following a plenary evidentiary hearing.
• IBM v. ASUS, Inv. No. 337-TA-628 (ITC 2011) (wireless routers and computer power management) Patent infringement on behalf of patent owner. Case settled favorably following a plenary evidentiary hearing.
• Israel Bio Engineering v. Amgen, Case No. 2:02cv6860 (C.D. Cal. 2002) (autoimmune disease therapeutics) Patent infringement. Resolved by successful summary judgment motions.
• IPR2015-01317 (USPTO 2015): Detachably Integrated Battery Charger for Mobile Cell Phones and Like Devices. Inter Partes Review on behalf of Petitioner. IPR and related district court cases settled favorably.